SIRPant Immunotherapeutics (now BobcatBio) to Present Trial in Progress Poster at the Society for Immunotherapy of Cancer 38th Annual Meeting

Previous PostImmunoGenesis Doses First Patient in Phase 1a/1b Clinical Trial of IMGS-001 in Relapsed or Refractory Advanced Solid Tumors